![]() |
|
|
Department of Pharmaceutical Sciences and the Pharmacology and
Toxicology Graduate Program, College of Pharmacy, Washington State
University
In the study of tissues that contain several forms of one
cytochrome P450 subfamily, it is useful to develop immunoblotting techniques so that the various individual members of the family can be
distinguished. This paper describes improvements in the immunoblotting
technique to distinguish members of the rat cytochrome P450 4A
subfamily, 4A1, 4A2, and 4A3, as they are present in Sprague-Dawley rat
liver microsomes. This procedure was used to investigate differences in
the cytochrome P450 4A forms observed under various conditions such as:
untreated versus peroxisome proliferator treated rats, Sprague-Dawley versus Fischer 344 male versus
female rats, and liver versus kidney microsomes. In liver
microsomes of male Sprague-Dawley rats, forms 4A1, 4A2, and 4A3 were
induced by the peroxisome proliferators, clofibrate, di-(2-ethylhexyl)
phthalate, dehydroepiandrosterone, aspirin, and ibuprofen. Expression
of the 4A forms shows strain specificity. A comparison of the
cytochrome P450 4A forms in male Sprague-Dawley and Fischer 344 rats
treated with peroxisome proliferators demonstrated that three distinct
protein bands are visible on immunoblots of liver microsomes of
Sprague-Dawley rats, whereas only two distinct protein bands are
detectable in liver microsomes of Fischer 344 rats. The two protein
bands in liver microsomes of male Fischer 344 rats migrate in positions
corresponding to the 4A2 and 4A3 bands in male Sprague-Dawley rats.
There did not appear to be a protein band corresponding to the 4A1 band
of Sprague-Dawley rats. Expression of the 4A forms also shows gender
specificity. In liver microsomes of female Sprague-Dawley rats,
expression of the P450 4A2 form was not observed after treatment with a
peroxisome proliferator. Expression of the 4A forms also shows tissue
specificity. In kidney, 4A2 is the major protein band in male
Sprague-Dawley rats with minor amounts of the 4A3 protein, whereas two
prominent protein bands (4A2 and 4A3) are seen in male Fischer 344 rats.
This article has been cited by other articles:
![]() |
S. M. Poloyac, M. A. Tortorici, D. I. Przychodzin, R. B. Reynolds, W. Xie, R. F. Frye, and M. A. Zemaitis THE EFFECT OF ISONIAZID ON CYP2E1- AND CYP4A-MEDIATED HYDROXYLATION OF ARACHIDONIC ACID IN THE RAT LIVER AND KIDNEY Drug Metab. Dispos., July 1, 2004; 32(7): 727 - 733. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Li-Masters and E. T. Morgan Effects of Bacterial Lipopolysaccharide on Phenobarbital-Induced CYP2B Expression in Mice Drug Metab. Dispos., March 1, 2001; 29(3): 252 - 257. [Abstract] [Full Text] |
||||
![]() |
X. Nguyen, M.-H. Wang, K. M. Reddy, J. R. Falck, and M. L. Schwartzman Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1999; 276(6): R1691 - R1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Cummings, R. C. Zangar, R. F. Novak, and L. H. Lash Cellular Distribution of Cytochromes P-450 in the Rat Kidney Drug Metab. Dispos., April 1, 1999; 27(4): 542 - 548. [Abstract] [Full Text] |
||||
![]() |
M.-H. Wang, H. Guan, X. Nguyen, B. A. Zand, A. Nasjletti, and M. Laniado-Schwartzman Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys Am J Physiol Renal Physiol, February 1, 1999; 276(2): F246 - F253. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Kroetz, P. Yook, P. Costet, P. Bianchi, and T. Pineau Peroxisome Proliferator-activated Receptor alpha Controls the Hepatic CYP4A Induction Adaptive Response to Starvation and Diabetes J. Biol. Chem., November 20, 1998; 273(47): 31581 - 31589. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Su, K. M. Kaushal, and D. L. Kroetz Inhibition of renal arachidonic acid omega -hydroxylase activity with ABT reduces blood pressure in the SHR Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R426 - R438. [Abstract] [Full Text] [PDF] |
||||